Wednesday, June 17, 2009
Novartis Produces First Batch of Swine Flu Vaccine
Novartis has produced a batch of experimental swine flu vaccine. Don't get your hopes up quite yet. The vaccine hasn't in been tested in humans yet. Instead of using eggs, this vaccine was deveoped using cell-based technology. In other words, the vaccine was made using cells, not eggs. I also heard that Baxter has completed testing and evaluation and is now in full-scale production of a commercial H1N1 vaccine using its Vero cell culture technology.
The WHO (Word Health Organization) is anticipating that swine flu (H1N1) vaccines should be ready and available by this fall. Let's hope that they are effective in controlling and reducing outbreaks this upcoming flu season as we face this pandemic.